"Hair shedding can occur with some GLP‑1 medications, especially with rapid weight loss - but it is usually temporary, reversible, and manageable. With good counseling, steady weight loss, and attention to nutrition, most patients can continue therapy safely."
"The study found that semaglutide and tirzepatide, the active ingredients in now-commercial drugs like Ozempic, Wegovy, Mounjaro and Zepbound, were all linked to notable levels of hair loss."
Approximately 15 million American adults have used GLP-1 drugs recently, with over 18% having tried them. Initially developed for diabetes, these medications are now impacting obesity rates. A study indicates that semaglutide and tirzepatide, found in drugs like Ozempic and Wegovy, can cause hair loss, particularly at higher doses. While those on lower doses for diabetes may experience less hair loss, it remains a possibility. Experts suggest that hair shedding is typically temporary and manageable with proper care and nutrition.
Read at Jezebel
Unable to calculate read time
Collection
[
|
...
]